In 2021, we used the National COVID Cohort Collaborative (N3C) as part of the National Institutes of Health RECOVER Initiative to develop a machine learning pipeline to identify patients with a high probability of having post-acute sequelae of SARS-CoV-2 infection or long COVID. However, the increased home testing, missing documentation, and reinfections that characterise the pandemic beyond 2022 necessitated the re-engineering of our original model to account for these changes in the COVID-19 research landscape. Trained on 72 745 patient records (36 238 with long COVID and 36 507 with no evidence of long COVID), our updated XGBoost model gathered data for each patient in overlapping 100-day periods that progressed through time and issued a probability of long COVID for each 100-day period. We ran the model on patients in N3C (n=5 875 065) who met at least one of the following criteria from Jan 1, 2020, to June 22, 2023: a U07·1 (COVID-19) diagnosis code; a positive SARS-CoV-2 test; a U09·9 (post-acute sequelae of SARS-CoV-2 infection) diagnosis code; a prescription for nirmatrelvir-ritonavir or remdesivir; or an M35·81 (multisystem inflammatory syndrome in children MIS-C) diagnosis code. Each patient was given a model score that predicted long COVID status for each 100-day window in which they were aged ≥18 years. If a patient had known acute COVID-19 during any 100-day window (including reinfections), we censored the data from 7 days before the diagnosis or positive test date to 28 days after. We ran the model on controls selected from pre-2020 data to assess the likelihood of false positives. The updated model had an area under the receiver operating characteristic curve of 0·90. Precision and recall could be adjusted according to a given use case, depending on whether greater sensitivity or specificity was warranted. Using our model, we estimate the overall prevalence of long COVID among the COVID-19 positive cohort within N3C repository to be 10.4%. By eschewing the COVID-19 index date as an anchor point for analysis, we can assess the probability of long COVID among patients who might have tested at home, or with suspected (but untested) cases of COVID-19, or multiple SARS-CoV-2 reinfections. We view this exercise as a model for maintaining and updating any machine learning pipeline used for clinical research and operations. National Institutes of Health RECOVER Initiative.
Crosskey et al. (Fri,) studied this question.